Blog
RSS FeedPosted by Michael Wonder on 24 Jan 2020
After years of campaigning, PHARMAC agrees to fund 'wonder drug' to treat kids with cystic fibrosis
24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund the long-campaigned for drug Kalydeco ...
Posted by Michael Wonder on 24 Jan 2020
PHARMAC seeking views on new cystic fibrosis medicine
24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) ...
Posted by Michael Wonder on 23 Jan 2020
Woman denied cancer drug on NHS which could extend her life because of where she lives
22 January 2020 - Ann, 64, can't get the drug she needs to survive because it's not available on the NHS ...
Posted by Michael Wonder on 23 Jan 2020
PHARMAC protest ride from Dunedin ends with conflict in Parliament
22 January 2020 - A couple’s tandem cycle ride from Dunedin to Wellington, to call for increased PHARMAC funding, has ...
Posted by Michael Wonder on 23 Jan 2020
Update of the frequently asked questions for the PBS Botulinum Toxin Program
23 January 2020 - A revised version of the frequently asked questions for the PBS Botulinum Toxin Program is now available. ...
Posted by Michael Wonder on 22 Jan 2020
Morneau says Ottawa will need to work with provinces on issues like universal pharmacare
19 January 2020 - Finance Minister Bill Morneau said that the federal government will often need to work together with provinces ...
Posted by Michael Wonder on 22 Jan 2020
NHS patients denied new lung cancer drug after another NICE deadlock
22 January 2020 - Certain untreated lung cancer patients on England’s NHS will have to make do with older drugs ...
Posted by Michael Wonder on 22 Jan 2020
EU group calls for 'targeted actions' to mitigate impact of Brexit
22 January 2020 - Committee wants to ensure safe supply of drugs and medical devices. ...
Posted by Michael Wonder on 22 Jan 2020
NICE rejects Janssen’s Stelara on cost efficiency grounds
22 January 2020 - NICE has released a draft guidance not recommending Janssen’s Stelara (ustekinumab) for moderately to severely active ...
Posted by Michael Wonder on 22 Jan 2020
Supporting innovative medicines funding in Scotland
21 January 2020 - Scotland receives superb value from the latest medicines and vaccines thanks to robust measures which ensure ...
Posted by Michael Wonder on 22 Jan 2020
Parents demanding PHARMAC funding boost unleash on politicians at Parliament steps
22 January 2020 - The parents of a daughter with cystic fibrosis have cycled 1300 km from Dunedin to Wellington ...
Posted by Michael Wonder on 22 Jan 2020
Amazon just filed a bunch of international trademarks for ‘Amazon Pharmacy’
21 January 2020 - Amazon bought an Internet pharmacy business called PillPack in 2018. ...
Posted by Michael Wonder on 21 Jan 2020
Achieving cost savings with biosimilars will require new strategies, authors say
20 January 2020 - Improving access to fairly priced, quality-assured generics and biosimilars is essential to realizing the potential public ...
Posted by Michael Wonder on 21 Jan 2020
Mum says 'miracle' drug saved ill baby Kaan Hunter's life
21 January 2020 - A baby who was given only four months to live after being diagnosed with an extremely ...
Posted by Michael Wonder on 21 Jan 2020
Health gap fees up to 10 times higher in northern Sydney than elsewhere in NSW
21 January 2020 - Private health insurance gap fees are up to 10 times larger in northern Sydney than elsewhere ...